can be achieved by 1,3‐chelation‐controlled allylation of aldehydes that possess a non‐chelating α‐ether substituent, even if the α‐position is a quaternary centre and/or a spiro‐epoxide. This reaction was used as a key step in an enantioselective synthesis of the angiogenesis inhibitor luminacin D.
通过具有非螯合α-醚取代基的醛的1,3-螯合控制的烯丙基化可以实现非常高的非对映选择性,即使α-位置为季中心和/或螺-
环氧化物。该反应被用作血管生成
抑制剂luminacin D的对映选择性合成中的关键步骤。